# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 15, "Clin Ophthalmol", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasJournal> \"Clin Ophthalmol\"."
1, PublicationYear, 18, 22, "2011", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasPublicationYear> \"2011\"."
116, Title, 92, 245, "Twelve - week , randomized , multicenter study comparing a fixed combination of brimonidine - timolol with timolol as therapy adjunctive to latanoprost .", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasTitle> \"Twelve - week , randomized , multicenter study comparing a fixed combination of brimonidine - timolol with timolol as therapy adjunctive to latanoprost .\"."
2, Duration, 92, 105, "Twelve - week", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasCTduration> \"Twelve - week\"."
3, Randomized, 108, 118, "randomized", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
4, Multicenter, 121, 132, "multicenter", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
5, Brimonidine, 172, 183, "brimonidine", "", "<http://ctro/data#Medication_65039> <http://ctro/data#hasDrug> <http://ctro/data#Brimonidine>."
6, Timolol, 186, 193, "timolol", "", "<http://ctro/data#Medication_65046> <http://ctro/data#hasDrug> <http://ctro/data#Timolol>."
7, Timolol, 199, 206, "timolol", "", 
8, Latanoprost, 232, 243, "latanoprost", "", "<http://ctro/data#Latanoprost_65054> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost>. <http://ctro/data#Medication_65053> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_65054>."
10, Author, 246, 257, "Fechtner RD", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasAuthor> \"Fechtner RD\"."
11, Author, 266, 280, "Harasymowycz P", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasAuthor> \"Harasymowycz P\"."
12, Author, 283, 291, "Nixon DR", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasAuthor> \"Nixon DR\"."
13, Author, 294, 301, "Vold SD", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasAuthor> \"Vold SD\"."
14, Author, 304, 311, "Zaman F", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasAuthor> \"Zaman F\"."
15, Author, 314, 325, "Williams JM", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasAuthor> \"Williams JM\"."
16, Author, 328, 340, "Hollander DA", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasAuthor> \"Hollander DA\"."
131, USA, 454, 457, "USA", "", "<http://ctro/data#Population_53589> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
132, ObjectiveDescription, 495, 696, "To evaluate the additive intraocular pressure ( IOP ) - lowering efficacy and safety of fixed - combination brimonidine 0 . 2 % / timolol 0 . 5 % compared with timolol 0 . 5 % at peak and trough effect", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasObjectiveDescription> \"To evaluate the additive intraocular pressure ( IOP ) - lowering efficacy and safety of fixed - combination brimonidine 0 . 2 % / timolol 0 . 5 % compared with timolol 0 . 5 % at peak and trough effect\"."
18, IOP, 520, 540, "intraocular pressure", "", 
19, IOP, 543, 546, "IOP", "", 
20, Brimonidine, 603, 614, "brimonidine", "", 
30, DoseValue, 615, 620, "0 . 2", "", "<http://ctro/data#Medication_65039> <http://ctro/data#hasDoseValue> \"0 . 2\"."
35, Percentage, 621, 622, "%", "", "<http://ctro/data#Medication_65039> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
21, Timolol, 625, 632, "timolol", "", 
31, DoseValue, 633, 638, "0 . 5", "", "<http://ctro/data#Medication_65046> <http://ctro/data#hasDoseValue> \"0 . 5\"."
36, Percentage, 639, 640, "%", "", "<http://ctro/data#Medication_65046> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
22, Timolol, 655, 662, "timolol", "", 
32, DoseValue, 663, 668, "0 . 5", "", 
37, Percentage, 669, 670, "%", "", 
23, Peak_IOP, 674, 678, "peak", "", 
146, Trough_IOP, 683, 689, "trough", "", 
133, ObjectiveDescription, 697, 840, "when used as therapy adjunctive to latanoprost 0 . 005 % in patients with glaucoma or ocular hypertension who require additional IOP lowering .", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasObjectiveDescription> \"when used as therapy adjunctive to latanoprost 0 . 005 % in patients with glaucoma or ocular hypertension who require additional IOP lowering .\"."
25, Latanoprost, 732, 743, "latanoprost", "", 
33, DoseValue, 744, 751, "0 . 005", "", "<http://ctro/data#Medication_65053> <http://ctro/data#hasDoseValue> \"0 . 005\"."
34, Percentage, 752, 753, "%", "", "<http://ctro/data#Medication_65053> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
26, Glaucoma, 771, 779, "glaucoma", "", "<http://ctro/data#Glaucoma_53575> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glaucoma>. <http://ctro/data#ClinicalTrial_53566> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Glaucoma_53575>."
27, OcularHypertension, 783, 802, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
28, IOP, 826, 829, "IOP", "", 
153, CTDesign, 859, 870, "prospective", "", "<http://ctro/data#CTDesign_53584> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTDesign>. <http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasCTDesign> <http://ctro/data#CTDesign_53584>."
40, Randomized, 873, 883, "randomized", "", 
41, Multicenter, 886, 897, "multicenter", "", 
42, Blind, 915, 921, "masked", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind>."
43, Parallel, 924, 932, "parallel", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
44, Latanoprost, 976, 987, "latanoprost", "", 
37010, Duration, 1013, 1023, "four weeks", "", 
47, Latanoprost, 1059, 1070, "latanoprost", "", 
50, Precondition, 1073, 1120, "patients with IOP ≥ 21 mmHg in at least one eye", "", "<http://ctro/data#Population_53589> <http://ctro/data#hasPrecondition> \"patients with IOP ≥ 21 mmHg in at least one eye\"."
48, IOP, 1087, 1090, "IOP", "", 
49, mmHg, 1096, 1100, "mmHg", "", 
51, Randomized, 1126, 1136, "randomized", "", 
52, Frequency, 1140, 1153, "twice - daily", "", "<http://ctro/data#Intervention_65060> <http://ctro/data#hasFrequency> \"twice - daily\". <http://ctro/data#Intervention_65068> <http://ctro/data#hasFrequency> \"twice - daily\"."
53, Brimonidine, 1160, 1171, "brimonidine", "", "<http://ctro/data#Intervention_65060> <http://ctro/data#hasFrequency> \"twice - daily\". <http://ctro/data#Intervention_65068> <http://ctro/data#hasFrequency> \"twice - daily\"."
54, Timolol, 1174, 1181, "timolol", "", 
55, NumberPatientsArm, 1188, 1191, "102", "", "<http://ctro/data#Arm_65090> <http://ctro/data#hasNumberPatientsArm> \"102\"."
56, Timolol, 1197, 1204, "timolol", "", 
57, NumberPatientsArm, 1211, 1214, "102", "", "<http://ctro/data#Arm_65099> <http://ctro/data#hasNumberPatientsArm> \"102\"."
58, Latanoprost, 1238, 1249, "latanoprost", "", 
46, Duration, 1254, 1262, "12 weeks", "", "<http://ctro/data#Intervention_65060> <http://ctro/data#hasDuration> \"12 weeks\". <http://ctro/data#Intervention_65068> <http://ctro/data#hasDuration> \"12 weeks\"."
59, IOP, 1265, 1268, "IOP", "", 
37014, TimePoint, 1303, 1311, "baseline", "", 
37013, TimePoint, 1314, 1320, "week 6", "", 
37015, TimePoint, 1327, 1334, "week 12", "", "<http://ctro/data#Outcome_102229> <http://ctro/data#hasTimePoint> \"week 12\"."
171, PerProtocol, 1356, 1368, "per protocol", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#PerProtocol>."
37016, Peak_IOP, 1416, 1424, "peak IOP", "", 
37018, TimePoint, 1445, 1452, "week 12", "", 
62, Mean, 1516, 1520, "mean", "", "<http://ctro/data#Mean_53599> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_53597> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_53599>."
63, IOP, 1521, 1524, "IOP", "", 
64, Brimonidine, 1572, 1583, "brimonidine", "", 
65, Timolol, 1586, 1593, "timolol", "", 
66, BaseLineValue, 1594, 1600, "23 . 4", "", "<http://ctro/data#Outcome_65012> <http://ctro/data#hasBaselineValue> \"23 . 4\"."
68, mmHg, 1601, 1605, "mmHg", "", "<http://ctro/data#Endpoint_53597> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
70, Timolol, 1608, 1615, "timolol", "", 
67, BaseLineValue, 1616, 1622, "23 . 0", "", "<http://ctro/data#Outcome_65108> <http://ctro/data#hasBaselineValue> \"23 . 0\"."
69, mmHg, 1623, 1627, "mmHg", "", 
71, Mean, 1636, 1640, "mean", "", 
72, Latanoprost, 1667, 1678, "latanoprost", "", 
74, IOP, 1698, 1701, "IOP", "", 
73, Reduction, 1706, 1711, "8 . 3", "", "<http://ctro/data#Outcome_65012> <http://ctro/data#hasChangeValue> \"8 . 3\"."
76, mmHg, 1712, 1716, "mmHg", "", 
81, RelativeReduction, 1719, 1725, "35 . 5", "", "<http://ctro/data#Outcome_65012> <http://ctro/data#hasRelativeChangeValue> \"35 . 5\"."
78, Brimonidine, 1741, 1752, "brimonidine", "", 
79, Timolol, 1755, 1762, "timolol", "", 
75, Reduction, 1767, 1772, "6 . 2", "", "<http://ctro/data#Outcome_65108> <http://ctro/data#hasChangeValue> \"6 . 2\"."
77, mmHg, 1773, 1777, "mmHg", "", 
82, RelativeReduction, 1780, 1786, "27 . 0", "", "<http://ctro/data#Outcome_65108> <http://ctro/data#hasRelativeChangeValue> \"27 . 0\"."
80, Timolol, 1796, 1803, "timolol", "", 
195, TimePoint, 1815, 1822, "week 12", "", "<http://ctro/data#Outcome_65012> <http://ctro/data#hasTimePoint> \"week 12\". <http://ctro/data#Outcome_65108> <http://ctro/data#hasTimePoint> \"week 12\". <http://ctro/data#Outcome_102256> <http://ctro/data#hasTimePoint> \"week 12\"."
83, PvalueDiff, 1825, 1836, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_65298> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
84, Brimonidine, 1869, 1880, "brimonidine", "", 
85, Timolol, 1883, 1890, "timolol", "", 
86, Latanoprost, 1905, 1916, "latanoprost", "", 
87, Timolol, 1986, 1993, "timolol", "", 
88, IOP, 2008, 2011, "IOP", "", 
203, EndPointDescription, 2008, 2021, "IOP < 18 mmHg", "", "<http://ctro/data#EndPointDescription_65217> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_65216> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_65217>."
89, mmHg, 2017, 2021, "mmHg", "", 
90, PvalueDiff, 2024, 2035, "P = 0 . 028", "", "<http://ctro/data#DiffBetweenGroups_65289> <http://ctro/data#hasPvalueDiff> \"P = 0 . 028\"."
205, EndPointDescription, 2044, 2081, "≥ 20 % reduction in IOP from baseline", "", "<http://ctro/data#EndPointDescription_65222> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_65221> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_65222>."
92, IOP, 2064, 2067, "IOP", "", 
91, PvalueDiff, 2084, 2095, "P = 0 . 047", "", "<http://ctro/data#DiffBetweenGroups_65226> <http://ctro/data#hasPvalueDiff> \"P = 0 . 047\"."
93, TimePoint, 2124, 2131, "week 12", "", "<http://ctro/data#Outcome_65235> <http://ctro/data#hasTimePoint> \"week 12\". <http://ctro/data#Outcome_65262> <http://ctro/data#hasTimePoint> \"week 12\"."
119921, EndPointDescription, 2134, 2148, "Adverse events", "", "<http://ctro/data#EndPointDescription_112627> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_112626> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_112627>."
94, PercentageAffected, 2161, 2167, "14 . 7", "", "<http://ctro/data#Outcome_65135> <http://ctro/data#hasPercentageAffected> \"14 . 7\"."
96, Brimonidine, 2179, 2190, "brimonidine", "", 
97, Timolol, 2193, 2200, "timolol", "", 
95, PercentageAffected, 2214, 2220, "12 . 7", "", "<http://ctro/data#Outcome_65162> <http://ctro/data#hasPercentageAffected> \"12 . 7\"."
98, Timolol, 2226, 2233, "timolol", "", 
214, Duration, 2316, 2324, "12 weeks", "", 
215, ConclusionComment, 2353, 2549, "Fixed - combination brimonidine - timolol reduced IOP significantly more effectively than timolol when used as adjunctive therapy to latanoprost in patients with glaucoma and ocular hypertension .", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasConclusionComment> \"Fixed - combination brimonidine - timolol reduced IOP significantly more effectively than timolol when used as adjunctive therapy to latanoprost in patients with glaucoma and ocular hypertension .\"."
100, Brimonidine, 2373, 2384, "brimonidine", "", 
101, Timolol, 2387, 2394, "timolol", "", 
103, IOP, 2403, 2406, "IOP", "", 
102, Timolol, 2443, 2450, "timolol", "", 
104, Latanoprost, 2486, 2497, "latanoprost", "", 
105, Glaucoma, 2515, 2523, "glaucoma", "", 
106, OcularHypertension, 2528, 2547, "ocular hypertension", "", 
216, ConclusionComment, 2550, 2652, "Both fixed brimonidine - timolol and timolol were well tolerated as agents adjunctive to latanoprost .", "", "<http://ctro/data#ClinicalTrial_53566> <http://ctro/data#hasConclusionComment> \"Both fixed brimonidine - timolol and timolol were well tolerated as agents adjunctive to latanoprost .\"."
107, Brimonidine, 2561, 2572, "brimonidine", "", 
108, Timolol, 2575, 2582, "timolol", "", 
109, Timolol, 2587, 2594, "timolol", "", 
110, Latanoprost, 2639, 2650, "latanoprost", "", 
113, PMID, 2711, 2719, "21792284", "", "<http://ctro/data#Publication_53553> <http://ctro/data#hasPMID> \"21792284\"."
